Manohar Kuppusami - Sartorius Aktiengesellscha Head India

SARTF Stock  USD 223.65  16.35  6.81%   

Insider

Manohar Kuppusami is Head India of Sartorius Aktiengesellschaft
Phone49 551 308 0
Webhttps://www.sartorius.com

Sartorius Aktiengesellscha Management Efficiency

The company has return on total asset (ROA) of 0.106 % which means that it generated a profit of $0.106 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3386 %, meaning that it generated $0.3386 on every $100 dollars invested by stockholders. Sartorius Aktiengesellscha's management efficiency ratios could be used to measure how well Sartorius Aktiengesellscha manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.65 B in total debt with debt to equity ratio (D/E) of 1.03, which is about average as compared to similar companies. Sartorius Aktiengesellscha has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Sartorius Aktiengesellscha until it has trouble settling it off, either with new capital or with free cash flow. So, Sartorius Aktiengesellscha's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sartorius Aktiengesellscha sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sartorius to invest in growth at high rates of return. When we think about Sartorius Aktiengesellscha's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Craig HarrisonRepligen
N/A
Euan ThomsonCarl Zeiss Meditec
60
Cindy ReissClarkWest Pharmaceutical Services
50
AM AMResMed Inc
80
Neil PetersonMerit Medical Systems
57
Laurie FergusonCarl Zeiss Meditec
N/A
Joanne EgaminoSTAAR Surgical
N/A
Kimberly MacKayWest Pharmaceutical Services
58
Scott MDSTAAR Surgical
62
Stephen TingleyRepligen
N/A
Molly JosephWest Pharmaceutical Services
46
BE MBAResMed Inc
50
Steven MDCarl Zeiss Meditec
N/A
Patrick WilliamsSTAAR Surgical
51
Jason TreftMerit Medical Systems
N/A
Rajwant SodhiResMed Inc
46
CPA ParraMerit Medical Systems
46
Robert SeguraWest Pharmaceutical Services
N/A
Richard LuzziWest Pharmaceutical Services
72
Brian BonnellICU Medical
50
Markus WeberCarl Zeiss Meditec
N/A
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company was founded in 1870 and is headquartered in Gttingen, Germany. Sartorius operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 13832 people. Sartorius Aktiengesellschaft [SARTF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Sartorius Aktiengesellscha Leadership Team

Elected by the shareholders, the Sartorius Aktiengesellscha's board of directors comprises two types of representatives: Sartorius Aktiengesellscha inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sartorius. The board's role is to monitor Sartorius Aktiengesellscha's management team and ensure that shareholders' interests are well served. Sartorius Aktiengesellscha's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sartorius Aktiengesellscha's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rene Faber, Member of the Executive Board, Head of the Bioprocess Solutions Division
Petra Kirchhoff, Member of the Supervisory Board, Vice President of Corporate Communications & Investor Relations
Rashid Maqbool, Head USA
Manfred Werner, Sr Auditing
John MacKay, Member of the Executive Board, Head of the Lab Products & Services Division
Patricia Spannagel, Head Goettingen
Mei Wang, Head China
Joachim Kreuzburg, Chairman of the Executive Board, CEO, Executive for Labor Relations
Rainer Lehmann, CFO, Member of the Executive Board
Manohar Kuppusami, Head India

Sartorius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Sartorius Aktiengesellscha a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sartorius Aktiengesellschaft. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Complementary Tools for Sartorius Pink Sheet analysis

When running Sartorius Aktiengesellscha's price analysis, check to measure Sartorius Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Aktiengesellscha is operating at the current time. Most of Sartorius Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Sartorius Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Aktiengesellscha's price. Additionally, you may evaluate how the addition of Sartorius Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Bonds Directory
Find actively traded corporate debentures issued by US companies
Please note, there is a significant difference between Sartorius Aktiengesellscha's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sartorius Aktiengesellscha is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sartorius Aktiengesellscha's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.